- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, August 18, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
A study from the May 2017 issue of The American Journal of Managed Care® (AJMC®) was discussed in a press release from Pennsylvania State University. In “State Prescription Drug Monitoring Programs and Fatal Drug Overdoses,” Penn State researchers found that prescription drug monitoring programs (PDMPs) were not associated with reduced mortality rates from prescription opioid overdoses. However, study co-author Yungfeng Shi, PhD, noted in the statement that the “results point to a potential unintended consequence of PDMPs, whereby reduced access to prescription drugs may have led some individuals with addictive disorders to look for alternatives.”
An article published by Huffington Post warned readers of “The Over-the-Counter Drug Reactions You Should Watch Out For,” including adverse reactions to non-steroidal anti-inflammatory drugs (NSAIDs). It cited a 2013 study published in an AJMC® supplement that showed that NSAID-related complications can be serious and costly. The report, “Quantifying the Impact of NSAID-Associated Adverse Events,” found that gastrointestinal complications from the painkillers are responsible for more than $4 billion in medical costs annually.
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
